Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Functional Genomics In Neuropsychiatric Disorders And In Neuropharmacology

E. Castrén, O. Kontkanen
Published 2002 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The rapidly accumulating amount of information concerning gene and protein expression patterns produced by functional genomics, proteomics and bioinformatics is presently providing new targets for drug development. Furthermore, the analysis of gene expression in cells and tissues affected by a disease may reveal the underlying metabolic pathways and cellular processes affected. Finally, changes in gene expression may be used in either diagnostics or the monitoring of drug responses. This review focuses on advances in the use of functional genomics in neurological and neuropsychiatric diseases and neuropsychopharmacology. Although the number of published studies in this field is still limited, it already appears that this strategy may become a fruitful means in the analysis of the aetiology of neuropsychiatric disorders and the search for novel neuropharmacological drugs.
This paper references
10.1016/S0014-5793(01)02503-0
Global gene expression during short‐term ethanol stress in Saccharomyces cerevisiae
H. Alexandre (2001)
10.1073/pnas.071056198
Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: Implications for the pathophysiology of psychiatric disorders
E. Thomas (2001)
10.1001/ARCHPSYC.57.3.237
Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia.
D. Volk (2000)
10.1126/science.270.5235.467
Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray
M. Schena (1995)
10.1038/sj.mp.4000866
Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia
K. Mirnics (2001)
10.1038/nbt1297-1359
Genome-wide expression monitoring in Saccharomyces cerevisiae
L. Wodicka (1997)
10.1038/35066591
Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5
J. Bibb (2001)
Microarray identification of FMRPassociated brain mRNAs and altered mRNA translational profiles in fragile X syndrome
V BROWN (2001)
The global burden of disease and injury
CJL MURRAY (1996)
10.1016/S0304-3940(00)01753-5
Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique
L. Ho (2001)
10.1152/PHYSIOLGENOMICS.2000.3.3.175
Large-scale analysis of gene expression changes during acute and chronic exposure to [Delta]9-THC in rats.
J. Kittler (2000)
10.1038/ng1201-365
Minimum information about a microarray experiment (MIAME)—toward standards for microarray data
A. Brazma (2001)
Seizures and the regulation of neurotrophic factor expression: associations with structural plasticity in epilepsy.
C. Gall (1997)
10.1038/nn1101-1155
Single-cell molecular biology
J. Eberwine (2001)
10.1016/S0006-8993(01)02685-3
Region-specific transcriptional response to chronic nicotine in rat brain
Özlen Konu (2001)
Thyroid stimulating hormone-receptor overexpression in brain of patients with Down’s syndrome and Alzheimer’s disease
O LABUDOVA (1999)
10.1046/j.1471-4159.2001.00231.x
Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays
A. Malaspina (2001)
10.1001/ARCHPSYC.1997.01830220065010
Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.
L. Glantz (1997)
10.1046/j.1471-4159.2001.00027.x
Clozapine increases apolipoprotein D expression in rodent brain: towards a mechanism for neuroleptic pharmacotherapy
E. Thomas (2001)
10.1016/S0304-3940(01)01820-1
Ethanol decreases the expression of mitochondrial cytochrome c oxidase mRNA in the rat
J. Kim (2001)
10.1016/S0169-328X(01)00186-3
Characterisation of gene expression changes following permanent MCAO in the rat using subtractive hybridisation.
S. Bates (2001)
10.1016/S0169-328X(00)00223-0
Gene expression profile in Alzheimer's brain screened by molecular indexing.
M. Doyu (2001)
10.1192/BJP.178.41.S137
Serial analysis of gene expression in the frontal cortex of patients with bipolar disorder.
Y. Sun (2001)
10.1126/SCIENCE.1354393
Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction.
P. Liang (1992)
10.1111/j.1471-4159.1990.tb01983.x
Induction of c‐fos mRNA Expression in Rat Striatum by Neuroleptic Drugs
J. Miller (1990)
10.1523/JNEUROSCI.21-16-j0004.2001
Synapse Formation between Central Neurons Requires Postsynaptic Expression of the MEN1 Tumor Suppressor Gene
R. V. van Kesteren (2001)
10.1006/BBRC.2000.3773
Identification of a novel gene with RING-H2 finger motif induced after chronic antidepressant treatment in rat brain.
M. Yamada (2000)
Increased CNS levels of apolipoprotein D in schizophrenic and Kontkanen & Castrén Expert Opin
EA THOMAS (2001)
10.1006/GENO.1999.6053
Molecular cloning of a novel apoptosis-related gene, human Nap1 (NCKAP1), and its possible relation to Alzheimer disease.
T. Suzuki (2000)
10.1073/PNAS.97.20.11038
Regional and strain-specific gene expression mapping in the adult mouse brain.
R. Sandberg (2000)
10.1016/S0024-3205(99)00030-2
Thyroid stimulating hormone-receptor overexpression in brain of patients with Down syndrome and Alzheimer's disease.
O. Labudova (1999)
10.1074/jbc.M107558200
KEPI, a PKC-dependent Protein Phosphatase 1 Inhibitor Regulated by Morphine*
Q. Liu (2002)
10.1016/S0006-3223(00)01080-5
The “chip” as a specific genetic tool
S. Watson (2000)
10.1046/j.0953-816x.2001.01779.x
Cystatin C, a cysteine protease inhibitor, is persistently up‐regulated in neurons and glia in a rat model for mesial temporal lobe epilepsy
E. Aronica (2001)
10.1016/S0165-0173(98)00018-6
Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins
T. Herdegen (1998)
10.1006/BBRC.1996.0612
mRNA differential display reveals Krox-20 as a neural plasticity-regulated gene in the rat hippocampus.
K. Inokuchi (1996)
Molecular cloning of a novel apoptosis-related gene, human Nap1 (NCKAP1) and its possible relation to Alzheimer’s disease
T SUZUKI (2000)
Regional and strainspecific gene expression mapping in the adult mouse brain
R SANDBERG (2000)
10.1097/00006676-200108000-00001
Chronic Ethanol Consumption Induces Gene Expression of Pancreatic Monitor Peptide, but not SPINK1/PSTI-56, in Rats
H. Li (2001)
10.1046/j.1471-4159.2001.00397.x
Gene expression analysis in N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R‐apomorphine
E. Grünblatt (2001)
10.1074/jbc.275.21.15621
Genomic and Functional Changes Induced by the Activation of the Peripheral Cannabinoid Receptor CB2 in the Promyelocytic Cells HL-60
J. M. Derocq (2000)
10.1046/j.1471-4159.2001.00096.x
Dopaminergic cell death induced by MPP+, oxidant and specific neurotoxicants shares the common molecular mechanism
H. Chun (2001)
10.1046/j.0953-816x.2001.01818.x
Seizure‐induced gene expression in area CA1 of the mouse hippocampus
P. French (2001)
10.1002/HIPO.1058
Expression profile of 30,000 genes in rat hippocampus using SAGE
N. Datson (2001)
10.1124/MOL.58.6.1593
Expression profiling of neural cells reveals specific patterns of ethanol-responsive gene expression.
C. Thibault (2000)
10.1016/S0920-9964(00)00052-9
Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia
M. Webster (2001)
10.1523/JNEUROSCI.20-19-07345.2000
The Human DIMINUTO/DWARF1 Homolog Seladin-1 Confers Resistance to Alzheimer's Disease-Associated Neurodegeneration and Oxidative Stress
I. Greeve (2000)
10.1006/BBRC.2001.4968
Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray.
R. Hata (2001)
Increase in activin beta A mRNA in rat hippocampus during long-term potentiation.
K. Inokuchi (1996)
10.1046/j.1471-4159.2001.00252.x
Chronic cocaine‐mediated changes in non‐human primate nucleus accumbens gene expression
W. Freeman (2001)
10.1046/j.0022-3042.2001.00683.x
Differential expression of inflammation‐ and apoptosis‐related genes in spinal cords of a mutant SOD1 transgenic mouse 
model of familial amyotrophic lateral sclerosis
Tsuyoshi Yoshihara (2002)
10.1001/archpsyc.1997.01830190088009
Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.
L. Glantz (1997)
10.1016/S1471-4914(01)01950-5
Searching for schizophrenia genes.
N. Bray (2001)
10.1016/S0169-328X(01)00007-9
Indexing-based differential display--studies on post-mortem Alzheimer's brains.
M. Ryan (2001)
10.1523/JNEUROSCI.20-04-01318.2000
Nicotine Enhances the Biosynthesis and Secretion of Transthyretin from the Choroid Plexus in Rats: Implications for β-Amyloid Formation
M. Li (2000)
10.1016/S0014-5793(00)01771-3
Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics
Julio E. Celis (2000)
10.1046/j.0953-816x.2001.01778.x
Altered hippocampal gene expression prior to the onset of spontaneous seizures in the rat post‐status epilepticus model
H. Hendriksen (2001)
10.1152/PHYSIOLGENOMICS.2000.4.1.83
Identifying a series of candidate genes for mania and psychosis: a convergent functional genomics approach.
A. Niculescu (2000)
10.1126/science.274.5287.610
Accessing Genetic Information with High-Density DNA Arrays
M. Chee (1996)
10.1038/47048
A combined algorithm for genome-wide prediction of protein function
E. Marcotte (1999)
Gene expression analysis of antipsychotic drug effects reveals long-lasting increases in fos and jun family genes in the rat prefrontal cortex
O KONTKANEN (2001)
10.1073/pnas.081071198
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia
Y. Hakak (2001)
10.1016/S0361-9230(01)00530-5
Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins
Sharon L. Eastwood (2001)
10.1002/1531-8249(199909)46:3<425::AID-ANA22>3.0.CO;2-O
Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays
Laurie Ward Whitney (1999)
10.1007/springerreference_118906
[Serial analysis of gene expression].
J. Huang (2002)
10.1016/S0092-8674(01)00568-2
Microarray Identification of FMRP-Associated Brain mRNAs and Altered mRNA Translational Profiles in Fragile X Syndrome
V. Brown (2001)
10.1523/JNEUROSCI.15-12-07872.1995
Nerve injury enhances rat neuronal glutamate transporter expression: identification by differential display PCR
S. Kiryu (1995)
10.1093/NAR/29.8.E41
An evaluation of the performance of cDNA microarrays for detecting changes in global mRNA expression.
H. Yue (2001)
10.1016/0306-4522(90)90399-O
D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons
M. Dragunow (1990)
10.1016/S0896-6273(00)00085-4
Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex
K. Mirnics (2000)
10.3109/13550289609146887
Visualization of viral candidate cDNAs in infectious brain fractions from Creutzfeldt-Jakob disease by representational difference analysis.
M. Dron (1996)
10.1126/SCIENCE.286.5439.531
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.
T. Golub (1999)
10.1073/pnas.091094698
Amygdala-enriched genes identified by microarray technology are restricted to specific amygdaloid subnuclei
M. Zirlinger (2001)
10.1073/pnas.141244998
Genome-wide gene expression profiles of the developing mouse hippocampus
M. Mody (2001)
10.1016/S0306-4522(01)00190-7
Up-regulation of secretoneurin immunoreactivity and secretogranin II mRNA in rat striatum following 6-hydroxydopamine lesioning and chronic L-DOPA treatment
A. Medhurst (2001)
(3) stress
(2000)
10.1073/PNAS.040537997
TOGA: an automated parsing technology for analyzing expression of nearly all genes.
J. Sutcliffe (2000)
10.1073/PNAS.90.8.3447
Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics.
K. Merchant (1993)
Defines standardised procedures for cDNA microarray experiments and their reporting
10.1016/S0896-6273(01)00209-4
A Genetic Analysis of Neural Progenitor Differentiation
D. Geschwind (2001)
10.1046/j.1471-4159.2001.00563.x
Induction of nuclear factor‐κB in nucleus accumbens by chronic cocaine administration
E. Ang (2001)
10.1073/PNAS.89.7.3010
Analysis of gene expression in single live neurons.
J. Eberwine (1992)
10.1101/GR.10.12.2006
The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals.
R. Chrast (2000)
10.1089/10445490152717541
A gene expression profile of Alzheimer's disease.
J. Loring (2001)
10.1152/PHYSIOLGENOMICS.2001.6.3.169
Gene expression following acute morphine administration.
A. Loguinov (2001)
10.1523/JNEUROSCI.16-14-04491.1996
Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease
T. Gómez-Isla (1996)
10.1096/fj.01-0593com
Long‐lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol
R. Rimondini (2002)
10.1073/pnas.041605498
Delineating developmental and metabolic pathways in vivo by expression profiling using the RIKEN set of 18,816 full-length enriched mouse cDNA arrays
R. Miki (2001)
10.1523/JNEUROSCI.20-24-09104.2000
Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus
J. Malberg (2000)
10.1038/4462
Exploring the new world of the genome with DNA microarrays
P. Brown (1999)
10.1016/0306-4522(92)90054-6
Neuroleptics increase C-FOS expression in the forebrain: Contrasting effects of haloperidol and clozapine
G. Robertson (1992)
10.1016/S1471-4914(01)02067-6
Genes and subtypes of schizophrenia.
K. Mirnics (2001)
10.1016/S0304-3940(01)01638-X
Induction of cysteine string protein after chronic antidepressant treatment in rat frontal cortex
M. Yamada (2001)
10.1006/GENO.2000.6284
Direct comparison of GeneChip and SAGE on the quantitative accuracy in transcript profiling analysis.
M. Ishii (2000)
10.1126/SCIENCE.1062960
The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease
D. Chabas (2001)
10.1016/S0022-3956(01)00061-9
Molecular characterisation of antidepressant effects in the mouse brain using gene expression profiling.
J. Landgrebe (2002)
10.1016/S0306-4522(01)00141-5
Cerebellar synaptic protein expression in schizophrenia
Sharon L. Eastwood (2001)
10.1152/PHYSIOLGENOMICS.2001.6.2.91
Rat mitochondrial ATP synthase ATP5G3: cloning and upregulation in pancreas after chronic ethanol feeding.
H. Li (2001)
10.1038/4475
DNA microarrays in drug discovery and development
C. Debouck (1999)
10.1126/science.8438152
Cloning the differences between two complex genomes
N. Lisitsyn (1993)
10.1016/0014-5793(96)00135-4
Increase in activin βA mRNA in rat hippocampus during long‐term potentiation
K. Inokuchi (1996)
10.1038/nbt1296-1675
Expression monitoring by hybridization to high-density oligonucleotide arrays
D. Lockhart (1996)
Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays.
L. Whitney (1999)
10.1002/jnr.1176
Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia
G. Pasinetti (2001)
10.1038/363718A0
Numerous candidate plasticity-related genes revealed by differential cDNA cloning
E. Nedivi (1993)
10.1016/S0165-5728(01)00438-6
Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions
L. Whitney (2001)
10.1176/AJP.156.11.1709
Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects.
J. Pierri (1999)
10.1038/35015694
Protein function in the post-genomic era
D. Eisenberg (2000)
10.1038/35000501
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Ash A. Alizadeh (2000)
10.1016/S0306-4522(01)00432-8
Cocaine-responsive gene expression changes in rat hippocampus
W. Freeman (2001)
10.1002/(SICI)1097-4547(20000101)59:1<1::AID-JNR1>3.0.CO;2-2
High throughput analysis of gene expression in the human brain
C. Colantuoni (2000)
10.1001/ARCHPSYC.1995.03950160008002
Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.
S. Akbarian (1995)
Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression.
H. Jiang (1995)
These two papers describe the application of microdissection in the analysis of transcript expression
10.1038/sj.mp.4000823
Differential expression of diacylglycerol kinase iota and L18A mRNAs in the brains of alcohol-preferring AA and alcohol-avoiding ANA rats
W. Sommer (2001)
10.1002/(SICI)1097-4695(199904)39:1<41::AID-NEU4>3.0.CO;2-X
Kainate-elicited seizures induce mRNA encoding a CaMK-related peptide: a putative modulator of kinase activity in rat hippocampus.
E. Vreugdenhil (1999)
) targeted to neuronal dendrites
(2001)
10.1523/JNEUROSCI.18-14-05301.1998
A Complex Program of Striatal Gene Expression Induced by Dopaminergic Stimulation
J. Berke (1998)
-scale correlation of mRNA expression data with other biological data sources revealed protein functions not detectable from the individual data sources
•• Large
10.1016/0378-1119(95)00023-Y
High-density cDNA filter analysis: a novel approach for large-scale, quantitative analysis of gene expression.
N. Zhao (1995)
10.1073/PNAS.89.10.4270
Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine.
T. V. Nguyen (1992)
10.1073/pnas.032069099
Gene expression analysis in schizophrenia: Reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22
M. Mimmack (2002)
10.1073/pnas.121146698
Local translation of classes of mRNAs that are targeted to neuronal dendrites
J. Eberwine (2001)
10.1016/S0165-6147(00)01741-7
DNA microarrays in neuropsychopharmacology.
E. Marcotte (2001)
10.1016/S0166-2236(00)01862-2
Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse
K. Mirnics (2001)
Differential cDNA cloning identified a large number of genes differentially regulated by seizure activity in the hippocampus
10.1016/S0361-9230(01)00522-6
Application of cDNA microarrays to examine gene expression differences in schizophrenia
M. Vawter (2001)
Gene expression changes in adult prefrontal cortex and nucleus accumbens following neonatal ventral hippocampal lesions
ER MARCOTTE (2000)
10.1016/S0893-133X(01)00358-X
Regulation of Adult Neurogenesis by Antidepressant Treatment
R. Duman (2001)
10.1006/BBRC.1999.1067
Identification of a novel splice variant of heat shock cognate protein 70 after chronic antidepressant treatment in rat frontal cortex.
M. Yamada (1999)
10.1073/PNAS.96.16.9212
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.
C. Perou (1999)
10.1523/JNEUROSCI.22-07-02718.2002
Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia
F. Middleton (2002)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar